South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 4,080 shares at $6.10 ($24K) on 2023-02-22, disclosed to the SEC on 2023-02-23.
Open-market purchase of $24k RANI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.94 | 3,080 | $18K | 75.0% |
| 2 | $6.10 | 1,000 | $6K | 25.0% |
| Total | $5.98 avg | 4,080 | $24K | 100% |
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |